Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Ekso Bionics is a pioneering company at the forefront of robotic exoskeleton technology. They design, develop, and commercialize innovative solutions aimed at augmenting human strength, endurance, and mobility. Their product portfolio serves both the medical market, with devices like EksoNR for neurorehabilitation and Ekso Indego for personal mobility, and the industrial sector, with exoskeletons like EksoEVO designed to reduce workplace injuries and enhance productivity. Ekso Bionics is committed to improving quality of life and revolutionizing human capabilities through advanced bionics.
The Emeryville headquarters serves as the central hub for Ekso Bionics' corporate leadership, research and development, engineering, clinical, and strategic operations, driving the innovation behind their exoskeleton technologies.
Located in a modern commercial office building within the dynamic Emeryville tech corridor, offering access to a skilled talent pool and fostering collaboration. The facility is designed to support advanced R&D and corporate functions.
Ekso Bionics fosters a collaborative, mission-driven, and innovative work culture. Employees are passionate about making a tangible difference in the medical and industrial fields by developing and advancing cutting-edge robotic solutions that improve people's lives.
The headquarters is significant as the nerve center for the company's global strategy, product development, and commercialization efforts. Its location in the San Francisco Bay Area positions Ekso Bionics within a leading U.S. ecosystem for technology and life sciences innovation.
Ekso Bionics supports its global operations through its U.S. headquarters in California and its European office in Germany. Their advanced exoskeleton solutions are distributed and utilized in numerous countries worldwide through a network of specialized distributors and direct sales channels. This allows them to reach rehabilitation clinics, hospitals, and industrial facilities internationally, with a focus on expanding global access to their transformative technology.
2200 Powell Street, Suite 450
Emeryville
CA
USA
Address: Ekso Bionics Europe GmbH, Industriepark an der A61, Nr. 3, 56283 Halsenbach, Germany
To provide localized support, facilitate market penetration, engage with key regional stakeholders, and ensure adherence to regional regulatory and commercial requirements for Ekso Bionics' products in Europe and surrounding territories.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Ekso Bionics' leadership includes:
Ekso Bionics has been backed by several prominent investors over the years, including:
Over the past 12 months (mid-2023 to mid-2024), Ekso Bionics has undergone significant leadership renewal. Key appointments include Scott Davis as permanent CEO, Jerome F. Wong as Chief Financial Officer, and Dr. Corinna Lathan as Chief Medical Officer. These changes followed the departures of former CEO Steven Sherman and former CFO Jack Glenn, marking a new phase for the company's executive leadership.
Discover the tools Ekso Bionics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Ekso Bionics commonly utilizes an email format that combines the first initial of an employee's name followed by their full last name. This is a standard professional structure for their corporate communications.
[first_initial][last]@eksobionics.com
Format
jdoe@eksobionics.com
Example
85%
Success rate
GlobeNewswire (Ekso Bionics IR) • May 9, 2024
Ekso Bionics announced its financial results for the first quarter of 2024, providing updates on revenue, gross profit, and operational milestones, including progress with its EksoNR and EksoHealth platforms....more
GlobeNewswire (Ekso Bionics IR) • April 22, 2024
Ekso Bionics announced its participation in the OT Show in the UK, highlighting its commitment to showcasing its latest advancements in exoskeleton technology for occupational therapy and neurorehabilitation to a key European audience....more
GlobeNewswire (Helius Medical Technologies IR) • February 20, 2024
Helius Medical Technologies and Ekso Bionics revealed a collaborative effort to explore the potential synergies of combining Helius's PoNS (Portable Neuromodulation Stimulator) therapy with Ekso's robotic exoskeletons to enhance neurorehabilitation outcomes for patients....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Ekso Bionics, are just a search away.